Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17185393rdf:typepubmed:Citationlld:pubmed
pubmed-article:17185393lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C0665341lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C0040624lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C0872079lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:17185393lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:17185393pubmed:issue4lld:pubmed
pubmed-article:17185393pubmed:dateCreated2007-3-28lld:pubmed
pubmed-article:17185393pubmed:abstractTextThe estrogen receptor (ER)alpha is a biologically and clinically important ligand-modulated transcription factor. The F domain of the ERalpha modulates its functions in a ligand-, promoter-, and cell-specific manner. To identify the region(s) responsible for these functions, we characterized the effects of serial truncations within the F domain. We found that truncating the last 16 residues of the F domain altered the activity of the human ERalpha (hERalpha) on an estrogen response element-driven promoter in response to estradiol or 4-hydroxytamoxifen (4-OHT), its sensitivity to overexpression of the coactivator steroid receptor coactivator-1 in mammalian cells, and its interaction with a receptor-interacting domain of the coactivator steroid receptor coactivator-1 or engineered proteins ("monobodies") that specifically bind to ERalpha/ligand complexes in a yeast two-hybrid system. Most importantly, the ability of the ER to induce pS2 was reduced in MDA-MB-231 cells stably expressing this truncated ER vs. the wild-type ER. The region includes a distinctive segment (residues 579-584; LQKYYIT) having a high content of bulky and/or hydrophobic amino acids that was previously predicted to adopt a beta-strand-like structure. As previously reported, removal of the entire F domain was necessary to eliminate the agonist activity of 4-OHT. In addition, mutation of the vicinal glycine residues between the ligand-binding domain and F domains specifically reduced the 4-OHT-dependent interactions of the hERalpha ligand-binding domain and F domains with monobodies. These results show that regions within the F domain of the hERalpha selectively modulate its activity and its interactions with other proteins.lld:pubmed
pubmed-article:17185393pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:languageenglld:pubmed
pubmed-article:17185393pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:citationSubsetIMlld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17185393pubmed:statusMEDLINElld:pubmed
pubmed-article:17185393pubmed:monthAprlld:pubmed
pubmed-article:17185393pubmed:issn0888-8809lld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:KoideAkikoAlld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:KoideShoheiSlld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:Deighton-Coll...lld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:ZhaoChangqing...lld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:SkafarDebra...lld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:AbramsJudithJlld:pubmed
pubmed-article:17185393pubmed:authorpubmed-author:NaganumaMisuz...lld:pubmed
pubmed-article:17185393pubmed:issnTypePrintlld:pubmed
pubmed-article:17185393pubmed:volume21lld:pubmed
pubmed-article:17185393pubmed:ownerNLMlld:pubmed
pubmed-article:17185393pubmed:authorsCompleteYlld:pubmed
pubmed-article:17185393pubmed:pagination829-42lld:pubmed
pubmed-article:17185393pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:meshHeadingpubmed-meshheading:17185393...lld:pubmed
pubmed-article:17185393pubmed:year2007lld:pubmed
pubmed-article:17185393pubmed:articleTitleIdentification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions.lld:pubmed
pubmed-article:17185393pubmed:affiliationDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois 60637, USA.lld:pubmed
pubmed-article:17185393pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17185393pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:17185393pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17185393pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:2099entrezgene:pubmedpubmed-article:17185393lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17185393lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17185393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17185393lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17185393lld:pubmed